Bajaj Healthcare Gears Up for Q2 Reveal on 29th October; Check Key Expectations Here

Name: Stock Advisory service In India
Brand: univest
Rating: 4.4 (197000 reviews)

Posted by : sachet | Thu Oct 16 2025

Bajaj Healthcare Gears Up for Q2 Reveal on 29th October; Check Key Expectations Here

Click and Sign Up to Get Live Updates on Q2 Results

Bajaj Healthcare Q2 Results: Bajaj Healthcare, a bulk drug manufacturer serving various pharmaceutical companies, is all set to announce its Q2 results for FY26 on 29th October 2025. Financial analysts anticipate an increase in revenue due to higher sales and significant growth in PAT.

Table of Contents

Bajaj Healthcare Q2 Results 2025 Preview

Bajaj Healthcare’s revenue is expected to be in the range of ₹3,304.53 crore to ₹4,568.76 crore, marking a healthy 54.6% to 67.4% YoY increase.
Profit After Tax, or PAT, is projected to rise by 32.70% YoY or 34.67% QoQ.
EBITDA of Bajaj Healthcare is expected to decrease by 15.00% YoY to ₹3,456.00 crore.
Gross Profit is expected to increase by 29.45%(QoQ) and 35.45%(YoY).

Bajaj Healthcare Share Performance

In the past six months, the share price of Bajaj Healthcare has fallen by 22.76% to reach ₹480.40.
Moreover, over the past year, the stock has risen by 25.86%.
Despite this weak short-term performance, Bajaj Healthcare’s stock has delivered a financially sound return of 32.15% over the past 5 years.
As of 16th October 2025, the stock traded at ₹480.35 per share, with a day high of ₹457.76.

Key Factors to Watch for Bajaj Healthcare

Bajaj Healthcare operates in a highly competitive market, facing pressure from both domestic and international brands.
The company’s in-house manufacturing capabilities enable better quality control and strategic operations.
Bajaj Healthcare’ performance is mainly linked to the broader economic cycle, and high inflation can reduce demand for its products.

Final Thoughts

Bajaj Healthcare will announce its Q2 FY26 results on 29th October, 2025. Analysts expect strong revenue growth of up to 54.76% YoY, a 32.40% rise in PAT, and a 15.00% increase in EBITDA. Bajaj Healthcare mainly focuses on the new products of this company and EBITDA growth.

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!